Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
PDF] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma | Oncohema Key
Full article: Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study
Lymphoma IPI Score Calculator - Apps on Google Play
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL - ScienceDirect
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Blood Cancer Journal
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table
Cancers | Free Full-Text | First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial
Baseline patient characteristics by CNS-IPI score | Download Table
Suggested approach to central nervous system risk stratification and... | Download Scientific Diagram
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
CNS-IPI in the study population | Download Table
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Jeremy Pantin (@JeremyPantinMD) / X
Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review - ScienceDirect
PDF) Relapsed/Refractory International Prognostic Index (R/ <scp>R‐IPI</scp> ): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma | Henrik Frederiksen - Academia.edu
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar